Key Record Dates
ClinicalTrials.gov Identifier: | NCT04466891 |
---|---|
Brief Title: | A Study of ZW25 (Zanidatamab) in Subjects With Advanced or Metastatic HER2-Amplified Biliary Tract Cancers (HERIZON-BTC-01) |
First Submitted : | July 6, 2020 |
First Submitted that Met QC Criteria : | July 6, 2020 |
First Posted : | July 10, 2020 |
Last Update Submitted that Met QC Criteria : | March 30, 2023 |
Last Update Posted : | March 31, 2023 (Estimate) |